Literature DB >> 3600817

Dobutamine: positive inotropy by nonselective adrenoceptor agonism in isolated guinea pig and human myocardium.

L Brown, M Näbauer, E Erdmann.   

Abstract

Positive inotropic responses to dobutamine have been examined using isolated myocardium from guinea pigs und humans. The potency (EC50) of dobutamine was 1.5 X 10(-6) mol/l on guinea pig papillary muscles, 1.8 X 10(-6) mol/l on guinea pig left atria and 2.5 X 10(-6) mol/l on human papillary muscle strips. In guinea pig cardiac muscles, Schild plots for the beta 1-selective antagonist, 1-practolol, using dobutamine as agonist, had slopes of less than unity. This suggested the involvement of other receptors in the inotropic response to dobutamine. The beta 2-selective antagonist, ICI 118,551, but not the alpha 1-selective antagonist, prazosin, attenuated the dobutamine response in guinea pig papillary muscles. Both ICI 118,551 and prazosin shifted the dobutamine concentration-response curve in guinea pig left atria. The positive inotropic response to dobutamine in human papillary muscles was antagonised by l-practolol and ICI 118,551 but not by prazosin. The maximal inotropic response to dobutamine was 90% that of calcium measured in the same guinea pig papillary muscles but only 37% that of calcium in human papillary muscle strips. This reduced maximal effect of dobutamine in human myocardium is probably a disease-induced change but species variations cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600817     DOI: 10.1007/bf00165552

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

Review 1.  Beta-adrenergic function in heart muscle disease and heart failure.

Authors:  M R Bristow; N E Kantrowitz; R Ginsburg; M B Fowler
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

2.  Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adrenoceptors mediating positive inotropic effects in human atrial preparations.

Authors:  J Wagner; H J Schümann; A Knorr; N Rohm; J C Reidemeister
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

3.  A differential inotropic responsiveness to isoprenaline and ouabain in dogs with heart failure.

Authors:  W H Newman; J G Webb
Journal:  Cardiovasc Res       Date:  1980-09       Impact factor: 10.787

4.  Effects of the beta 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium.

Authors:  A Mügge; D Posselt; U Reimer; W Schmitz; H Scholz
Journal:  Klin Wochenschr       Date:  1985-01-02

5.  Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium.

Authors:  R Brückner; W Meyer; A Mügge; W Schmitz; H Scholz
Journal:  Eur J Pharmacol       Date:  1984-04-06       Impact factor: 4.432

6.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

7.  Drugs five years later. Dobutamine.

Authors:  C V Leier; D V Unverferth
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

8.  An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity.

Authors:  T P Kenakin
Journal:  J Pharmacol Exp Ther       Date:  1981-02       Impact factor: 4.030

9.  Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol.

Authors:  R Ginsburg; M R Bristow; M E Billingham; E B Stinson; J S Schroeder; D C Harrison
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

10.  The inotropic effects of dopamine and its precursor levodopa on isolated human ventricular myocardium.

Authors:  L Brown; B Lorenz; E Erdmann
Journal:  Klin Wochenschr       Date:  1985-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.